Biospective specializes in advanced image processing and statistical image analysis for human brain imaging studies, including Phase I-III clinical trials. We are fully GCP and 21 CFR Part 11 compliant. We have a solid track-record of delivering data of the highest quality to our sponsors.
Our fully-automated PIANO™ software is the only comprehensive package available for multi-modality MRI and PET studies.
1.5 and 3T MRI
- Anatomical imaging
- Cerebral cortical thickness and volume
- Hippocampal volume
- Ventricular volume
- Subcortical volumes
- Volume-based morphometry (VBM)
- Tensor-based morphometry (TBM)
- Diffusion imaging
- Magnetization transfer (MT) imaging
- Arterial spin labeling (ASL) perfusion imaging
- Resting-state and task-based BOLD fMRI
- MR spectroscopy (MRS)
- Amyloid imaging
- FDG PET
- Receptor mapping
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Tourette Syndrome
- Lysosomal Storage Diseases
Do not hesitate to contact us to discuss studies for other CNS diseases.
Posters & Publications
Charil A, Carbonell F, Zijdenbos AP, Evans AC, Koeppe RA, Sevigny J, Chiao P, Bedell BJ. Comparison of reference regions for [18F]Florbetapir PET SUVR computation. Human Amyloid Imaging Conference 2014, Miami, FL, USA.
Carbonell F, Charil A, Zijdenbos AP, Evans AC, Sevigny J, Chiao P, Bedell BJ. Statistically-driven automated subject classification based on amyloid PET scans. Human Amyloid Imaging Conference 2014, Miami, FL, USA.
Lerch JP, Pruessner JC, Zijdenbos A, Hampel H, Teipel SJ, Evans AC. Focal decline of cortical thickness in Alzheimer disease identified by computational neuroanatomy. Cereb Cortex 2005;15(7):995-1001.
Our experts are always available to meet your specific needs. Please do not hesitate to contact our clinical team.Contact Us